TOTUM-63: Clinical Trials

2 trials of TOTUM-63, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Completed 1
Phase 31Completed 1

Follow TOTUM-63: new trials by email Literature Review of TOTUM-63 trials Research Report on TOTUM-63

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk
TOTUM-63 - Prediabetic State, Dysglycemia
Not applicableCompletedValbiotis202022-04-252023-11-13
Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes
Totum-63, Placebo - Prediabetes, Type 2 Diabetes
Phase 2 / Phase 3CompletedValbiotis662016-10-012020-10-05

Conditions studied

Obesity (2)  ·  Prediabetic State (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Disease (1)  ·  Hypertriglyceridemia (1)  ·  Insulin Resistance (1)  ·  Overweight (1)

Sponsors

Valbiotis (2)

Countries

Canada (1)  ·  France (1)  ·  Ireland (1)  ·  Serbia (1)  ·  Slovenia (1)

Top investigators

Patrick Couture, MD FRCP PhD (1)